BridgeBio完成Bbp-418在肢體帶狀肌肉萎縮症2I/R9（Lgmd2I/R9）的

快訊 · 09/30 19:30

BridgeBio Completes Enrollment of Fortify, Phase 3 Registrational Study of Bbp-418 in Limb-Girdle Muscular Dystrophy Type 2I/R9 (Lgmd2I/R9)

BridgeBio完成Bbp-418在肢體帶狀肌肉萎縮症2I/R9（Lgmd2I/R9）的Fortify第3期註冊研究招募。